DE202010001716U1 - Melissa, magnesium, basic salts and B vitamins containing composition - Google Patents
Melissa, magnesium, basic salts and B vitamins containing composition Download PDFInfo
- Publication number
- DE202010001716U1 DE202010001716U1 DE202010001716U DE202010001716U DE202010001716U1 DE 202010001716 U1 DE202010001716 U1 DE 202010001716U1 DE 202010001716 U DE202010001716 U DE 202010001716U DE 202010001716 U DE202010001716 U DE 202010001716U DE 202010001716 U1 DE202010001716 U1 DE 202010001716U1
- Authority
- DE
- Germany
- Prior art keywords
- range
- vitamin
- bis
- composition
- magnesium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 239000011777 magnesium Substances 0.000 title claims abstract description 13
- 229910052749 magnesium Inorganic materials 0.000 title claims abstract description 13
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title claims abstract description 11
- 235000019156 vitamin B Nutrition 0.000 title claims abstract description 5
- 239000011720 vitamin B Substances 0.000 title claims abstract description 5
- 150000001447 alkali salts Chemical class 0.000 title claims abstract description 4
- 235000010654 Melissa officinalis Nutrition 0.000 claims abstract description 12
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 9
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 9
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 9
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 9
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 9
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 5
- 239000011707 mineral Substances 0.000 claims abstract description 5
- 235000010755 mineral Nutrition 0.000 claims abstract description 5
- 235000016709 nutrition Nutrition 0.000 claims abstract description 4
- 206010022998 Irritability Diseases 0.000 claims abstract description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 claims abstract description 3
- 206010038743 Restlessness Diseases 0.000 claims abstract description 3
- 230000036772 blood pressure Effects 0.000 claims abstract description 3
- 239000012141 concentrate Substances 0.000 claims abstract description 3
- 239000011785 micronutrient Substances 0.000 claims abstract description 3
- 235000013369 micronutrients Nutrition 0.000 claims abstract description 3
- 235000015872 dietary supplement Nutrition 0.000 claims abstract 2
- 230000035764 nutrition Effects 0.000 claims abstract 2
- 235000019160 vitamin B3 Nutrition 0.000 claims abstract 2
- 239000011708 vitamin B3 Substances 0.000 claims abstract 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 13
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 12
- 244000062730 Melissa officinalis Species 0.000 claims description 11
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 10
- 241001529735 Melissa Species 0.000 claims description 10
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 8
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 claims description 8
- 229930003268 Vitamin C Natural products 0.000 claims description 8
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 8
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- 229960002685 biotin Drugs 0.000 claims description 8
- 235000020958 biotin Nutrition 0.000 claims description 8
- 239000011616 biotin Substances 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- 235000019175 phylloquinone Nutrition 0.000 claims description 8
- 239000011772 phylloquinone Substances 0.000 claims description 8
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 8
- 229960001898 phytomenadione Drugs 0.000 claims description 8
- 235000019154 vitamin C Nutrition 0.000 claims description 8
- 239000011718 vitamin C Substances 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 7
- 229930003451 Vitamin B1 Natural products 0.000 claims description 7
- 229930003779 Vitamin B12 Natural products 0.000 claims description 7
- 229930003471 Vitamin B2 Natural products 0.000 claims description 7
- 239000011713 pantothenic acid Substances 0.000 claims description 7
- 229960003975 potassium Drugs 0.000 claims description 7
- 239000011591 potassium Substances 0.000 claims description 7
- 229910052700 potassium Inorganic materials 0.000 claims description 7
- 235000007686 potassium Nutrition 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 7
- 229960002477 riboflavin Drugs 0.000 claims description 7
- 229960003495 thiamine Drugs 0.000 claims description 7
- 235000010374 vitamin B1 Nutrition 0.000 claims description 7
- 239000011691 vitamin B1 Substances 0.000 claims description 7
- 235000005282 vitamin D3 Nutrition 0.000 claims description 7
- 239000011647 vitamin D3 Substances 0.000 claims description 7
- 229940011671 vitamin b6 Drugs 0.000 claims description 7
- 229940021056 vitamin d3 Drugs 0.000 claims description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- 229960000304 folic acid Drugs 0.000 claims description 5
- 235000019152 folic acid Nutrition 0.000 claims description 5
- 239000011724 folic acid Substances 0.000 claims description 5
- 229940055726 pantothenic acid Drugs 0.000 claims description 5
- 235000019161 pantothenic acid Nutrition 0.000 claims description 5
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims description 5
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- 229940045997 vitamin a Drugs 0.000 claims description 5
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims description 4
- 229960003966 nicotinamide Drugs 0.000 claims description 4
- 235000005152 nicotinamide Nutrition 0.000 claims description 4
- 239000011570 nicotinamide Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 3
- 239000007938 effervescent tablet Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000001508 potassium citrate Substances 0.000 claims description 3
- 229960002635 potassium citrate Drugs 0.000 claims description 3
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 3
- 235000011082 potassium citrates Nutrition 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 229940091250 magnesium supplement Drugs 0.000 claims 3
- 229930003316 Vitamin D Natural products 0.000 claims 1
- 229960005336 magnesium citrate Drugs 0.000 claims 1
- 239000004337 magnesium citrate Substances 0.000 claims 1
- 235000002538 magnesium citrate Nutrition 0.000 claims 1
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 claims 1
- 235000019166 vitamin D Nutrition 0.000 claims 1
- 239000011710 vitamin D Substances 0.000 claims 1
- 150000003710 vitamin D derivatives Chemical class 0.000 claims 1
- 229940046008 vitamin d Drugs 0.000 claims 1
- 239000000865 liniment Substances 0.000 abstract description 4
- 230000033764 rhythmic process Effects 0.000 abstract description 2
- 241000021559 Dicerandra Species 0.000 abstract 1
- 235000017807 phytochemicals Nutrition 0.000 abstract 1
- 229930000223 plant secondary metabolite Natural products 0.000 abstract 1
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 150000001860 citric acid derivatives Chemical class 0.000 description 3
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 2
- 239000000347 magnesium hydroxide Substances 0.000 description 2
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930005346 hydroxycinnamic acid Natural products 0.000 description 1
- 235000010359 hydroxycinnamic acids Nutrition 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-N trans-4-coumaric acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-N 0.000 description 1
- 235000019195 vitamin supplement Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Eine Melisse, Magnesium, mindestens ein basisch wirkendes Salz und B-Vitamine B1, B2, B3, B6 und B12 enthaltende Zusammensetzung als Nahrungsergänzung bei stress- und ernährungsbedingten Mangel an Mikronährstoffen, Mineralstoffen und Sekundären Pflanzenstoffen, zur Reduktion von Stress, innerer Unruhe und Reizbarkeit, zu einer Verbesserung der Lebensqualität und Konzentrationsfähigkeit sowie zur Förderung des normalen, gesunden Blutdrucks und Herzrhythmus.A balm, magnesium, at least one basic salt and B vitamins B1, B2, B3, B6 and B12 containing composition as a dietary supplement in stress and nutrition-related lack of micronutrients, minerals and phytochemicals, to reduce stress, inner restlessness and irritability to improve the quality of life and ability to concentrate and to promote normal, healthy blood pressure and heart rhythm.
Description
Die vorliegende Erfindung betrifft eine Melisse, Magnesium, basisch wirkende Salze und B-Vitamine enthaltende Zusammensetzung, die insbesondere zur Nahrungsergänzung bei stress- und ernährungsbedingten Mangel an Mikronährstoffen, Mineralstoffen und Pflanzenstoffen geeignet ist.The The present invention relates to a melissa, magnesium, basic acting salts and B vitamins containing composition, in particular for nutritional support in stress and nutritional Lack of micronutrients, Minerals and plant substances is suitable.
Im Stand der Technik ist eine Verwendung von Vitaminpräparaten, Basenmittel, Melisse und Magnesium in separater Form bekannt. Allerdings müssten zur gleichen Wirkung verschiedenste Präparate kombiniert werden, um die gleichen synergistischen Effekte zu erhalten. Es ist daher die Aufgabe der vorliegenden Erfindung, ein Mittel zur Verfügung zu stellen, das durch synergistische Effekte in einem Mittel alle Wirkprinzipien vereint und den Nachteil des Standes der Technik überwindet.in the The prior art is a use of vitamin supplements, Basenmittel, melissa and magnesium in separate form known. However, would have to same effect a variety of preparations are combined to to get the same synergistic effects. It is therefore the Object of the present invention to provide a means to By synergistic effects in one agent, all the principles of action united and overcomes the disadvantage of the prior art.
Diese Aufgabe wird gelöst durch eine Melisse, Magnesium, basisch wirkende Salze und B-Vitamine enthaltende Zusammensetzung.These Task is solved by a balm, containing magnesium, basic salts and B vitamins Composition.
Überraschend konnte festgestellt werden, dass die erfindungsgemässe Zusammensetzung zur Reduktion von Stress, innerer Unruhe und Reizbarkeit, zu einer Verbesserung der Lebensqualität, zur Förderung des normalen, gesunden Blutdrucks und Herzrhythmus, vermehrten inneren Ruhe und Konzentrationsfähigkeit beitragen kann.Surprised could be found that the inventive composition to reduce stress, inner restlessness and irritability, to one Improving the quality of life, to promote of normal, healthy blood pressure and heart rhythm, increased internal Calm and ability to concentrate can contribute.
Melisse wird verwendet als ”Extrakt” (Auszug von Melissenblättern), das insbesondere auf Hydroxyzimtsäure und Rosmarinsäure standardisiert ist, und/oder Melissenblattpulver.balm is used as an "extract" (extract from Balm leaves) in particular standardized to hydroxycinnamic acid and rosmarinic acid is, and / or lemon balm powder.
Kalium und Magnesium werden bevorzugt als Citrate verwendet, da Citrate eine hohe basische Wirkung auf den Stoffwechsel haben.potassium and magnesium are preferably used as citrates, since citrates have a high basic effect on the metabolism.
Die Zusammensetzung umfasst vorzugsweise weiterhin wenigstens ein Vitamin oder Vitamingemisch ausgewählt aus der Gruppe umfassend Vitamin B1, Vitamin B2, B3, Vitamin B6, Vitamin B12, Folsäure, Pantothensäure und/oder Biotin; Vitamin C, Vitamin E und Vitamin A, Vitamin K1 und Vitamin D3 sowie den Mineralstoff Kalium.The Composition preferably further comprises at least one vitamin or vitamin mixture selected from the group comprising vitamin B1, vitamin B2, B3, vitamin B6, Vitamin B12, folic acid, pantothenic acid and / or biotin; Vitamin C, Vitamin E and Vitamin A, Vitamin K1 and vitamin D3 as well as the mineral potassium.
In bevorzugten Ausführungsformen umfasst die Zusammensetzung, bezogen auf eine Tagesdosis der Zusammensetzung, als wirksame Bestandteile die Stoffe:
- – Vitamin B1 im Bereich von >= 0,2 mg bis <= 20 mg, vorzugsweise im Bereich von >= 0,5 mg bis <= 10 mg, bevorzugt im Bereich von >= 0,9 mg bis <= 3 mg; und/oder
- – Vitamin B2 im Bereich von >= 0,2 mg bis <= 20 mg, vorzugsweise im Bereich von >= 0,5 mg bis <= 10 mg, bevorzugt im Bereich von >= 0,9 mg bis <= 3 mg; und/oder
- – Nicotinamid im Bereich von >= 3 mg bis <= 60 mg, vorzugsweise im Bereich von >= 10 mg bis <= 30 mg, bevorzugt im Bereich von >= 12 mg bis <= 20 mg; und/oder
- – Vitamin B6 im Bereich von >= 0,2 mg bis <= 20 mg, vorzugsweise im Bereich von >= 0,5 mg bis <= 10 mg, bevorzugt im Bereich von >= 0,9 mg bis <= 3 mg; und/oder
- – Vitamin B12 im Bereich von >= 0,5 μg bis <= 1000 μg, vorzugsweise im Bereich von >= 1 μg bis <= 50 μg, bevorzugt im Bereich von >= 2 μg bis <= 5 μg; und/oder
- – Folsäure im Bereich von >= 50 μg bis <= 1 mg, vorzugsweise im Bereich von >= 100 μg bis <= 500 μg, bevorzugt im Bereich von >= 150 μg bis <= 300 μg; und/oder
- – Pantothensäure im Bereich von >= 2 mg bis <= 100 mg, vorzugsweise im Bereich von >= 4 mg bis <= 40 mg, bevorzugt im Bereich von >= 5 mg bis <= 10 mg; und/oder
- – Magnesium im Bereich von >= 20 mg bis <= 1000 mg, vorzugsweise im Bereich von >= 100 mg bis <= 600 mg, bevorzugt im Bereich von >= 300 mg bis <= 400 mg; und/oder
- – Citrate im Bereich von >= 20 mg bis <= 2000 mg, vorzugsweise im Bereich von 100 mg bis <= 1000 mg, bevorzugt im Bereich von 200 mg bis <= 500 mg
- – Melissenextrakt im Bereich von >= 5 mg bis <= 1000 mg, vorzugsweise im Bereich von 20 mg bis <= 700 mg, bevorzugt im Bereich von 200 mg bis <= 400 mg
- – Melissenblätter im von >= 5 mg bis <= 1000 mg, vorzugsweise im Bereich von 20 mg bis <= 700 mg, bevorzugt im Bereich von 100 mg bis <= 300 mg
- – Kalium im Bereich von >= 20 mg bis <= 1500 mg, vorzugsweise im Bereich von >= 100 mg bis <= 600 mg, bevorzugt im Bereich von >= 300 mg bis <= 500 mg; und/oder
- – Vitamin K1 im Bereich von >= 10 μg bis <= 120 μg, vorzugsweise im Bereich von >= 40 μg bis <= 100 μg, bevorzugt im Bereich von >= 50 μg bis <= 80 μg; und/oder
- – Vitamin D3 im Bereich von >= 1 μg bis <= 20 μg, vorzugsweise im Bereich von >= 2 μg bis <= 10 μg, bevorzugt im Bereich von >= 4 μg bis <= 7 μg; und/oder
- – Vitamin C im Bereich von >= 10 mg bis <= 1000 mg, vorzugsweise im Bereich von >= 20 mg bis <= 500 mg, bevorzugt im Bereich von >= 50 mg bis <= 100 mg; und/oder
- – Vitamin E im Bereich von >= 5 mg bis <= 100 mg, vorzugsweise im Bereich von >= 7 mg bis <= 50 mg, bevorzugt im Bereich von >= 9 mg bis <= 20 mg; und/oder
- – Biotin im Bereich von >= 20 μg bis <= 800 μg, vorzugsweise im Bereich von >= 30 μg bis <= 200 μg, bevorzugt im Bereich von >= 40 μg bis <= 80 μg; und/oder
- – Vitamin A im Bereich von >= 100 μg bis <= 1 mg, vorzugsweise im Bereich von >= 300 μg bis <= 900 μg, bevorzugt im Bereich von >= 650 μg bis <= 850 μg; und/oder
- - vitamin B1 in the range of> = 0.2 mg to <= 20 mg, preferably in the range of> = 0.5 mg to <= 10 mg, preferably in the range of> = 0.9 mg to <= 3 mg; and or
- Vitamin B2 in the range of> = 0.2 mg to <= 20 mg, preferably in the range of> = 0.5 mg to <= 10 mg, preferably in the range of> = 0.9 mg to <= 3 mg; and or
- Nicotinamide in the range of> = 3 mg to <= 60 mg, preferably in the range of> = 10 mg to <= 30 mg, preferably in the range of> = 12 mg to <= 20 mg; and or
- Vitamin B6 in the range of> = 0.2 mg to <= 20 mg, preferably in the range of> = 0.5 mg to <= 10 mg, preferably in the range of> = 0.9 mg to <= 3 mg; and or
- - Vitamin B12 in the range of> = 0.5 μg to <= 1000 μg, preferably in the range of> = 1 μg to <= 50 μg, preferably in the range of> = 2 μg to <= 5 μg; and or
- Folic acid in the range of> = 50 μg to <= 1 mg, preferably in the range of> = 100 μg to <= 500 μg, preferably in the range of> = 150 μg to <= 300 μg; and or
- Pantothenic acid in the range of> = 2 mg to <= 100 mg, preferably in the range of> = 4 mg to <= 40 mg, preferably in the range of> = 5 mg to <= 10 mg; and or
- Magnesium in the range of> = 20 mg to <= 1000 mg, preferably in the range of> = 100 mg to <= 600 mg, preferably in the range of> = 300 mg to <= 400 mg; and or
- Citrates in the range of> = 20 mg to <= 2000 mg, preferably in the range of 100 mg to <= 1000 mg, preferably in the range of 200 mg to <= 500 mg
- - Melissa extract in the range of> = 5 mg to <= 1000 mg, preferably in the range of 20 mg to <= 700 mg, preferably in the range of 200 mg to <= 400 mg
- Melissa leaves in the range of> = 5 mg to <= 1000 mg, preferably in the range of 20 mg to <= 700 mg, preferably in the range of 100 mg to <= 300 mg
- Potassium in the range of> = 20 mg to <= 1500 mg, preferably in the range of> = 100 mg to <= 600 mg, preferably in the range of> = 300 mg to <= 500 mg; and or
- - Vitamin K1 in the range of> = 10 μg to <= 120 μg, preferably in the range of> = 40 μg to <= 100 μg, preferably in the range of> = 50 μg to <= 80 μg; and or
- - Vitamin D3 in the range of> = 1 μg to <= 20 μg, preferably in the range of> = 2 μg to <= 10 μg, preferably in the range of> = 4 μg to <= 7 μg; and or
- Vitamin C in the range of> = 10 mg to <= 1000 mg, preferably in the range of> = 20 mg to <= 500 mg, preferably in the range of> = 50 mg to <= 100 mg; and or
- Vitamin E in the range of> = 5 mg to <= 100 mg, preferably in the range of> = 7 mg to <= 50 mg, preferably in the range of> = 9 mg to <= 20 mg; and or
- - Biotin in the range of> = 20 μg to <= 800 μg, preferably in the range of> = 30 μg to <= 200 μg, preferably in the range of> = 40 μg to <= 80 ug; and or
- - Vitamin A in the range of> = 100 μg to <= 1 mg, preferably in the range of> = 300 μg to <= 900 μg, preferably in the range of> = 650 μg to <= 850 μg; and or
Die Zusammensetzung kann als Getränkepulver, Tablette, Kapseln, Granulat, Lösungen, Dispersionen und/oder Brausetabletten mit gleicher oder unterschiedlicher Zusammensetzung zur Anwendung kommen.The Composition can be used as a beverage powder, Tablet, capsules, granules, solutions, Dispersions and / or effervescent tablets with the same or different Composition come to application.
In besonders bevorzugten Ausführungsformen umfasst die Zusammensetzung, bezogen auf eine Tagesdosis der Zusammensetzung, als wirksame Bestandteile die Stoffe:
- – 375 mg Magnesium
- – 340 mg Kalium
- – 300 mg Melissenextrakt
- – 200 mg Melissenpulver
- – 80 mg Vitamin C;
- – 12 mg Vitamin E;
- – 1,1 mg Vitamin B1;
- – 1,4 mg Vitamin B2;
- – 16 mg Nicotinamid;
- – 1,4 mg Vitamin B6;
- – 2,5 μg Vitamin B12;
- – 75 μg Vitamin K1;
- – 5 μg Vitamin D3;
- – 200 μg Folsäure;
- – 6 mg Pantothensäure;
- – 50 μg Biotin;
- - 375 mg of magnesium
- - 340 mg of potassium
- - 300 mg lemon balm extract
- - 200 mg lemon balm powder
- - 80 mg of vitamin C;
- - 12 mg of vitamin E;
- - 1.1 mg of vitamin B1;
- - 1.4 mg of vitamin B2;
- - 16 mg nicotinamide;
- - 1.4 mg of vitamin B6;
- - 2.5 μg of vitamin B12;
- - 75 μg vitamin K1;
- - 5 μg vitamin D3;
- - 200 μg folic acid;
- - 6 mg pantothenic acid;
- - 50 μg biotin;
Nachfolgende
Beispiele dienen zur Veranschaulichung der vorliegenden Erfindung: Beispiel 1: Tablette
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE202010001716U DE202010001716U1 (en) | 2010-02-01 | 2010-02-01 | Melissa, magnesium, basic salts and B vitamins containing composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE202010001716U DE202010001716U1 (en) | 2010-02-01 | 2010-02-01 | Melissa, magnesium, basic salts and B vitamins containing composition |
Publications (1)
Publication Number | Publication Date |
---|---|
DE202010001716U1 true DE202010001716U1 (en) | 2010-05-27 |
Family
ID=42221359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE202010001716U Expired - Lifetime DE202010001716U1 (en) | 2010-02-01 | 2010-02-01 | Melissa, magnesium, basic salts and B vitamins containing composition |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE202010001716U1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105249128A (en) * | 2015-11-06 | 2016-01-20 | 上海立足生物科技有限公司 | Vitamin group B solid beverage |
CN108651808A (en) * | 2018-04-24 | 2018-10-16 | 山东溪润植物医药研究有限公司 | A kind of potassium citrate sodium bicarbonate effervescent tablet and preparation method thereof |
-
2010
- 2010-02-01 DE DE202010001716U patent/DE202010001716U1/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105249128A (en) * | 2015-11-06 | 2016-01-20 | 上海立足生物科技有限公司 | Vitamin group B solid beverage |
CN108651808A (en) * | 2018-04-24 | 2018-10-16 | 山东溪润植物医药研究有限公司 | A kind of potassium citrate sodium bicarbonate effervescent tablet and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE102006056454A1 (en) | Taste-free, granular nutritional supplement, useful e.g. for preventing osteoporosis and psoriasis, contains synergistic combination of Spirulina, Chlorella and Lithothamnium algae | |
DE102011013224A1 (en) | Orthomolecular remedy for the effects of alcohol consumption | |
DE202006014588U1 (en) | Carotenoid containing product, preferably a balanced diet supplement, useful for age-related eye diseases, comprises vitamins, carotenoids, flavonoids, sulfur containing amino acids, zinc, selenium, chrome, taurine and omega-3-fatty acid | |
EP2207435A1 (en) | Functional drink | |
DE202007013532U1 (en) | Composition containing phospholipids, suitable for strengthening the brain and memory function | |
DE102010036451B4 (en) | Composition and its use for reducing body weight and / or improving endurance and regeneration after exercising a physical activity | |
DE202010001716U1 (en) | Melissa, magnesium, basic salts and B vitamins containing composition | |
DE202009002126U1 (en) | Trace element-containing composition | |
EP2376094A1 (en) | Cactus fruit extract | |
US11357810B2 (en) | Compositions with purified Bombyx mori cocoon silk peptide fiber and refined Buglossoides arvensis seed oil having synergistic effects for improving memory, focus, and cognitive function, and related methods | |
DE202016000774U1 (en) | Magnesium, potassium, basic salts, melissa and B vitamins containing composition | |
DE202004013660U1 (en) | Vitamin-containing product for nutritional supplementation, useful in cases of cardiovascular disease, also promotes bone formation | |
CN107372861B (en) | Composition and application thereof in preparation of product for improving hyperlipidemia | |
DE202015102038U1 (en) | Caffeinated composition | |
EP3111930B1 (en) | Composition for treating depression, bipolar disorders, recurrent medical depressive disorders and other long-term affective disorders | |
DE102014118772B4 (en) | Dietary supplement in capsule form containing Chinese medicinal mushrooms and their use | |
EP2508082B1 (en) | Food supplement preparation with amino acids and spice extract | |
DE202014008500U1 (en) | Composition containing Rhodiola rosea, Bacopa monnieri and pantothenic acid for mental performance. | |
CN115702906A (en) | Composition for preventing and improving cardiovascular diseases | |
EP1348343B1 (en) | Dietary supplement composition | |
WO2022179889A1 (en) | Powdered food supplement for producing a beverage | |
CA3155362A1 (en) | Methods and compositions with purified bombyx mori cocoon silk peptide fiber and refined buglossoides arvensis seed oil providing anti-inflammatory effects and neuroprotection for disease states | |
DE202021103666U1 (en) | Herbal food composition for making a cereal porridge | |
DE102010036452A1 (en) | Composition and its use for reducing body weight and / or improving endurance and regeneration after exercising a physical activity | |
WO2012022373A1 (en) | Two-phase preparation and use thereof for the treatment of herpes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R207 | Utility model specification |
Effective date: 20100701 |
|
R150 | Term of protection extended to 6 years |
Effective date: 20130227 |
|
R157 | Lapse of ip right after 6 years | ||
R079 | Amendment of ipc main class |
Free format text: PREVIOUS MAIN CLASS: A23L0001300000 Ipc: A23L0033100000 |